← The Wire
AGMBNasdaq
Agomab Therapeutics NV
Biological Products, (No Diagnostic Substances) · C9 · CIK 2020932
Developing novel disease-modifying therapies for fibro-inflammatory diseases
$473M
Market cap
$17.82
Last close
+29.0%
1D
+50.5%
5D
200K
Volume
Price · last 39 sessions+47.2%
May 4L $9.61 · H $17.82Jun 29
7
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
Similar companies
Comparable business profile · signals at a glance